ARCHIVES

NCI Letter To Pittsburgh Details Deficiencies In NSABP Operations

This article is from The Cancer Letter archive.

Vol. 20 No. 14 | April 8, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010